Cited by 173Neuroinflammation and Neurodegeneration MechanismsImmune Response and InflammationInflammasome and immune disorders

Toll-like Receptors in Defense and Damage of the Central Nervous System

Aravalli, Rajagopal N., Peterson, Phillip K., Lokensgard, James R.·2007·Journal of Neuroimmune Pharmacology

Abstract

Members of the Toll-like receptor (TLR) family play critical roles as regulators of innate and adaptive immune responses. TLRs function by recognizing diverse molecular patterns on the surface of invading pathogens. In the brain, microglial cells generate neuroimmune responses through production of proinflammatory mediators. The upregulation of cytokines and chemokines in response to microbial products and other stimuli has both beneficial and deleterious effects. Emerging evidence demonstrates a central role for TLRs expressed on microglia as a pivotal factor in generating these neuroimmune responses. Therefore, understanding the basis of TLR signaling in producing these responses may provide insights into how activated microglia attempt to strike a balance between defense against invading pathogens and inflicting irreparable brain damage. These insights may lead to innovative therapies for CNS infections and neuroinflammatory diseases based on the modulation of microglial cell activation through TLR signaling.

Integrity signals

Registry

Crossref · 10.1007/s11481-007-9071-5

Cites

192 of 192 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aravalli, R. N., Peterson, P. K., & Lokensgard, J. R.
Affiliations
University of Minnesota (US)
Corresponding author
Lokensgard, James R.
Venue
Journal of Neuroimmune Pharmacology
Published
2007-04-03
Volume
2
Issue
4
Pages
297-312
ISSN
  • 1557-1890 (ISSN-L)
  • 1557-1904
OpenAlex
W2067505623
Cited by
173
References
192
Citations by year
2026: 1 · 2025: 6 · 2024: 2 · 2023: 9 · 2022: 9 · 2021: 6 · 2020: 5 · 2019: 10 · 2018: 7 · 2017: 6 · 2016: 12 · 2015: 11 · 2014: 10 · 2013: 11 · 2012: 14
FWCI
1.04
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuroimmune Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service
  • National Institute of Mental Health (MH-066703, R01MH066703)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
Toll-like receptors, microglia, neuroimmune response, innate immunity, neuroinflammation, central nervous system infection, Toll-like receptor signaling, inflammatory cytokines, chemokines, neuroprotection, neurodegeneration
MeSH terms
Animals, Central Nervous System, Central Nervous System Diseases, Humans, Signal Transduction, Toll-Like Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review